Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 2, 2000, Pages 363-372

  Froud, Peter J ^a,b,d,e   Mates, Donna ^a,d   Jackson, Jeremy S H ^a,e   Phillips, Norm ^d   Andersen, Sandra ^a,d   Jackson, Stewart M ^b,d,f   Bryce, Cicely J ^a,c,d,f   Olivotto, Ivo A ^a,b,d,f  

^a Breast Cancer Outcomes Unit   (Canada)

^b Radiation   (Canada)

^c Systemic Ther Prog Brit C   (Canada)

^d Vancouver Cancer Center   (Canada)

^e Fraser Valley Cancer Centre   (Canada)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Ipsilateral breast recurrence; Partial mastectomy; Radiotherapy; Time interval

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENCE RISK; TIME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TAMOXIFEN; TIME FACTORS;

EID: 0033978961     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00412-5     Document Type: Article

References (36)

1. Clark R.M., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer an update . J Natl Cancer Inst. 88:(22):1996;1659-1664.
2. Fisher B., Anderson S., Redmond C.K., et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 333:(22):1995;1456-1461.
3. Forrest A.P., Stewart H.J., Everington D., et al. Randomised controlled trial of conservation therapy for breast cancer;6-year analysis of the Scottish trial. Lancet. 348:1996;708-713.
4. Hermann R.E., Esselstyn C.B. Jr, Grundfest-Broniatowski S., et al. Partial mastectomy without radiation is adequate treatment for patients with stages 0 and I carcinoma of the breast. Surg Gynecol Obstet. 177:1993;247-253.
5. Liljegren G., Holmberg L., Adami H.O., et al. Sector resection with or without postoperative radiotherapy for stage I breast cancer Five-year results of a randomized trial . J Natl Cancer Inst. 86:(9):1994;717-722.
6. Veronesi U., Luini A., Del Vecchio M., et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med. 328:(22):1993;1587-1591.
7. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Breast radiotherapy after breast-conserving surgery. Can Med Assoc J 1998;158(Suppl 3):S35-S42.
8. Wallgren A., Bernier J., Gelber R.D., et al. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. Int J Radiat Oncol Biol Phys. 35:(4):1996;649-659.
9. Mackillop W.J., Zhou Y., Quirt C.F.A. Comparison of delays in the treatment of cancer with radiation in Canada and the United States. Int J Radiat Oncol Biol Phys. 32:(2):1995;531-539.
10. Slotman B.J., Meyer O.W.M., Njo K.H., et al. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol. 30:1994;206-212.
11. Buchholz T.A., Austin-Seymour M., Moe R.E., et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 26:1993;23-35.
12. Recht A., Come S.E., Gelman R.S., et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer Sequencing, timing, and outcome . J Clin Oncol. 9:(9):1991;1662-1667.
13. Recht A., Come S.E., Henderson C., et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 33421:1996;1356-1361.
14. Meek A.G., Park T.L., Weiss T.A., et al. Effect of delayed radiation therapy on local control in breast conservation therapy. Radiology. 200:1996;615-619.
15. Clarke D.H., Lê M.G., Sarrazin D., et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy experience of the Institut Gustave-Roussy . Int J Radiat Oncol Biol Phys. 11:1985;137-145.
16. Nixon A.J., Recht A., Neuberg D., et al. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys. 30:(1):1994;17-21.
17. Vujovic O., Perera F., Dar A.R., et al. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys. 40:(4):1998;869-874.
18. Olivotto I.A., Bajdik C.D., Plenderleith I.H., et al. Adjuvant systemic therapy and survival after breast cancer. N Engl J Med. 330:(12):1994;805-810.
19. Olivotto I.A., Coldman A.J., Hislop T.G., et al. Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol. 15:1997;216-222.
20. Clay M.G., Hislop T.G., Kan L., et al. Screening mammography in British Columbia 1988-1993 . Am J Surg. 167:1994;490-492.
21. Sawka C., Olivotto I., Coldman A., et al. The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer. Br J Cancer. 75:(10):1997;1534-1542.
22. Olivotto I.A., Weir L.M., Kim-Sing C., et al. Late cosmetic results of short fractionation for breast conservation. Radiother Oncol. 41:1996;7-13.
23. De La Rochefordiére A., Abner A.L., Silver B., et al. Are cosmetic results following conservative surgery and radiation therapy for early breast cancer dependent on technique? Int J Radiat Oncol Biol Phys. 23:1992;925-931.
24. Fowble B.L., Solin L.J., Schultz D.J., et al. Ten year results of conservative surgery and irradiation for stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 21:1991;269-277.
25. Hermanek P., Sobin L.H. UICC TNM classification of malignant tumours. 4th ed. 2nd rev. 1992;Springer-Verlag, Berlin.
26. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer I. The value of histopathological grade in breast cancer: experience from a large study with long-term follow-up . Histopathology. 19:1991;403-410.
27. ICD-O. International classification of diseases for oncology; 2nd ed. Geneva: World Health Organization; 1990.
28. Schulgen G., Schmoor C., Sauerbrei W., Schumacher M. A note on estimating local recurrence rates in clinical trials on the treatment of breast cancer. Breast Can Res Treat. 49:1998;87-91.
29. Pepe M.S., Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med. 12:1993;737-751.
30. Peterson M.E., Schultz D.J., Reynolds C., Solin L.J. Outcomes in breast-cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy the University of Pennsylvania experience . Int J Radiat Oncol Biol Phys. 43:(5):1999;1029-1035.
31. Dalberg K., Johansson H., Johansson U., et al. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. Cancer. 82:(11):1998;2204-2211.
32. Ribeiro G.G., Dunn G., Swindell R., et al. Conservation of the breast using two different radiotherapy techniques Interim report of a clinical trial . Clin Oncol. 2:1990;27-34.
33. Fisher B., Dignam J., Bryant J., et al. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst. 88:(21):1996;1529-1542.
34. Bentzen S.M., Skoczylas J.Z., Overgaard M., et al. Radiotherapy-related lung fibrosis enhanced by tamoxifen. J Natl Cancer Inst. 88:(13):1996;918-922.
35. Würschmidt F, Bünemann H, Ehnert M; et al. Is the time interval between surgery and radiotherapy important in operable nonsmall cell lung cancer? A retrospective analysis of 340 cases. Int J Radiat Oncol Biol Phys 1997;39(3):553-559.
36. Barton MB, Morgan G, Smee R; et al. Does waiting time affect the outcome of larynx cancer treated by radiotherapy? Radiother Oncol 1997;44:37-141.